Search Within

Chaitanya Divgi

  1. "Neeta Pandit-Taskar"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
  3. Book Section (1)
Groups
  1. Molecular Imaging and Therapy Service (28)
  2. Radiology, Department of (28)
  3. Department of Medicine (19)
  4. GSK Faculty (13)
  5. Molecular Pharmacology and Chemistry Program Faculty (13)
  6. Sloan Kettering Institute Faculty (13)

More Groups

People
  1. Neeta Pandit-Taskar (28)
  2. Steven Larson (13)
  3. Howard Scher (7)
  4. Michael Morris (7)
  5. Ronald Finn (7)
  6. John Humm (6)

More People

Years
  1. 2011 (2)
  2. 2010 (1)
  3. 2009 (1)
  4. 2008 (1)
  5. 2007 (4)
  6. 2006 (4)

More Years

Publications
  1. Journal of Nuclear Medicine (6)
  2. Clinical Cancer Research (4)
  3. Blood (3)
  4. Current Oncology Reports (2)
  5. European Journal of Nuclear Medicine and Molecular Imaging (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (6)
  2. Springer (5)
  3. American Association for Cancer Research (4)
  4. American Society of Hematology (3)
  5. American Society of Clinical Oncology (2)
  6. C M P Medica LLC * The Oncology Group (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Radioimmunotherapy: Current status and future directions
    Book Section

    Pandit-Taskar, N.; Divgi, C. R.
    In An, Z. (Eds.) Therapeutic Monoclonal Antibodies: From Bench to Clinic (2009)

    Fulltext@MSK | Save
  • Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: Lesion detectability and dosimetric projections for 90Y radioimmunotherapy
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Morris, M. J.; Wills, E. A.; Schwartz, L. H.; Gonen, M.; Scher, H. I.; Larson, S. M.; Divgi, C. R.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: A pilot trial testing two dose levels
    Journal Article

    Krug, L. M.; Milton, D. T.; Jungbluth, A. A.; Chen, L. C.; Quaia, E.; Pandit-Taskar, N.; Nagel, A.; Jones, J.; Kris, M. G.; Finn, R.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma
    Journal Article

    Iwamoto, F. M.; Schwartz, J.; Pandit-Taskar, N.; Peak, S.; Divgi, C. R.; Zelenetz, A. D.; Humm, J.; Abrey, L. E.
    Cancer (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions
    Meeting Abstract

    Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save